Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Treatment/Intervention:  complementary or alternative medicine procedure
Results 1-25 of 81 for your search:
Start Over
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: 97115, NCI-2011-02073, CDR0000674208, WFU 97115, WF-97115, MDA-04-01, NCT01141231
Acupressure in Controlling Nausea in Young Patients with Central Nervous System or Solid Tumors Receiving Nausea-Inducing Chemotherapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: 4 to 18
Trial IDs: SCUSF 1202, NCI-2011-02668, ACCL1032, CDR0000699766, COG-ACCL1032, NCT01346267
Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Patients with Early-Stage Breast Cancer
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: Postmenopausal
Trial IDs: S1200, NCI-2012-00251, CDR0000725249, SWOG-S1200, NCT01535066
Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors
Status: Not yet active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: URCC14040, NCI-2015-01144, RSRB052271, NCT02613364
The Effects of Ginseng on Cancer-Related Fatigue
Status: Active
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0854, NCI-2011-01127, NCT01375114
Acupuncture or Gabapentin in Treating Breast Cancer Survivors With Hot Flashes
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: UPCC 16108, NCI-2009-01315, NCT01005108
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: IOM-HNC-201-IL, NCI-2015-01924, NCT01400620
Genistein in Reducing the Toxicity and Improving the Efficacy of Bacillus Calmette Guerin Intravesical Therapy in Patients with Bladder Cancer
Status: Not yet active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: EU2010-11, NCI-2014-02088, NCI-2014-02072, NCT01489813
Combination Chemotherapy, Bevacizumab, and Cholecalciferol in Treating Patients with Previously Untreated Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-436, NCI-2012-00662, NCT01516216
Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents
Status: Active
Phase: Phase II
Type: Educational/Counseling/Training, Supportive care
Age: 11 to 24
Trial IDs: ANUR1131, NCI-2012-00682, CDR0000726664, COG-ANUR1131, NCT01556256
Ascorbic Acid, Gemcitabine Hydrochloride, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 75
Trial IDs: 11D.365, NCI-2012-00340, 2008-52(1), NCT01555489
Fish Oil in Preventing Colorectal Cancer in Participants Previously Diagnosed with Colon Polyps
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 to 79
Trial IDs: VICC GI 14138, NCI-2015-00480, 11165, GI 14138, NCI-2015-00070, NCT01661764
Curcumin in Reducing Fatigue in Patients with Chemotherapy-Treated Breast Cancer Undergoing Radiotherapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: WINSHIP2139-11, NCI-2014-02195, NCT01740323
Calcitriol before Surgery in Preventing Calcium Loss in Patients Undergoing Thyroidectomy
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: TC-P2-CALCITRIOL, NCI-2014-00962, NCT01868750
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients with Localized Prostate Cancer Undergoing Active Surveillance
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 21 and over
Trial IDs: CO11378, NCI-2014-00695, N01-CN-2012-00033, UWI2013-00-01, NCT02095145
Curcumin and Cholecalciferol in Treating Patients with Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 5913, NCI-2014-00266, NCT02100423
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GHNSCLC-2 001, NCI-2014-02209, NCT02047344
A Mouth Rinse Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: SAN005-01, NCI-2015-02029, NCT02399228
High-Dose Ascorbic Acid in Treating Patients with Stage IIIB-IV Non-small Cell Lung Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201412760, NCI-2015-00709, NCT02420314
Hypnotherapy and Relaxation Therapy in Improving Body, Self-Image and Sexuality in Patients with Breast or Gynecologic Cancer
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 and over
Trial IDs: UMCC 2015.081, NCI-2016-00036, HUM00100709, NCT02531997
Noni Extract in Treating Patients with Very Low Risk or Low Risk Prostate Cancer Undergoing Active Surveillance
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: Huang-2015-1, NCI-2016-00082, NCT02648919
IH636 Grape Seed Proanthocyanidin Extract and Cholecalciferol in Reducing Inflammation in Patients with Advanced Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: MUSC CTO 101839, NCI-2013-00692, 101839, MS13_Pro00020929, Pro00020929, NCT01820299
Gemcitabine Hydrochloride, Ascorbic Acid, and Radiation Therapy in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201310772, NCI-2014-00824, GAX-PAN-I, NCT01852890
Start Over